학술논문
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy
Document Type
Article
Author
Hurtado-Navarro, L.; Cuenca-Zamora, E.J.; Martínez-Banaclocha, H.; Martínez-Alarcón, L.; García-Palenciano, C.; Morales, M.L.; Jerez, A.; Lozano, M.L.; Teruel-Montoya, R.; Pelegrín, P.; Ferrer-Marín, F.; Soler-Espejo, E.; Marco-Ayala, J.; Chen-Liang, T.H.; Zamora, L.; Bellosillo, B.; Such, E.; Hernández-Rivas, J.M.; González, T.; Linares-Latorre, L.; García-Ávila, S.; Amat-Martínez, P.; Arnan, M.; Pomares-Marín, H.; Carreño-Tarragona, G.; Herranz, M.T.
Source
In: Cell Reports Medicine . (Cell Reports Medicine, 19 December 2023, 4(12))
Subject
Language
English
ISSN
26663791